
Met4min GP 2mg/500mg/15mg Tablet
Marketer
Troikaa Pharmaceuticals Ltd
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Met4min GP 2mg/500mg/15mg Tablet
Gluco-Met Trio (2mg/500mg/15mg) tablets combine medications to manage blood glucose in adults with type 2 diabetes. Used alongside diet and exercise, this triple-action formulation enhances insulin effectiveness, reducing blood sugar. Dosage and duration should strictly follow your physician's instructions; take with food to minimize digestive discomfort. Missed doses should be taken promptly unless nearing the next scheduled dose; never double up. Excessive dosage can cause dangerously low blood sugar (hypoglycemia). Concurrent use with other diabetes medications, alcohol, or skipped meals increases hypoglycemia risk; regular blood glucose monitoring is crucial. Common side effects may include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to use, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals require medical consultation before commencing treatment. Kidney function tests are routinely performed before prescription. Limit alcohol consumption as it can heighten side effect potential.
Uses of Met4min GP 2mg/500mg/15mg Tablet
Managing type 2 diabetes
Major Benefits of Met4min GP 2mg/500mg/15mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Met4min GP 2mg/500mg/15mg Tablet should be administered with a meal.
Common Side effects of Met4min GP 2mg/500mg/15mg Tablet:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Met4min GP 2mg/500mg/15mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Met4min GP 2mg/500mg/15mg Tablet should be administered with a meal.
How Met4min GP 2mg/500mg/15mg Tablet works:
Met4min GP tablets (2mg/500mg/15mg) combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents. Their complementary actions enhance blood glucose management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by reducing hepatic glucose production, slowing intestinal glucose absorption, and improving insulin responsiveness. Pioglitazone, a thiazolidinedione, further boosts insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining alcohol and Met4min GP 2mg/500mg/15mg tablets poses a safety risk.
PregnancyCONSULT YOUR DOCTOR
Using Met4min GP 2mg/500mg/15mg tablets during pregnancy might pose risks. While human research is scant, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible dangers before prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Met4min GP 2mg/500mg/15mg tablets while breastfeeding is likely unsafe. Available human data indicates potential transfer of the medication into breast milk, posing a risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should use Met4min GP 2mg/500mg/15mg tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Met4min GP 2mg/500mg/15mg tablets. Physician consultation is advised. Regular kidney function monitoring is recommended during treatment.
LiverCAUTION
Patients with liver impairment should exercise caution when using Met4min GP 2mg/500mg/15mg Tablets, potentially requiring dosage modification. A physician's consultation is advised. Met4min GP 2mg/500mg/15mg Tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Met4min GP 2mg/500mg/15mg Tablet :
Should you forget a Met4min GP 2mg/500mg/15mg Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Met4min GP 2mg/500mg/15mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
